The field of neuroscience is constantly seeking innovative compounds to unravel the complexities of brain function and develop effective therapies for cognitive disorders. At the forefront of this research is HBT1, a critical pharmaceutical intermediate that has demonstrated significant potential in enhancing cognitive function and advancing our understanding of neurological processes. As a reliable manufacturer and supplier, we are dedicated to providing researchers with access to this high-purity compound.

HBT1, also identified as YDL223C and bearing the CAS number 489408-02-8, plays a pivotal role in research due to its dual-action mechanism. Firstly, it acts as a potent AMPA receptor potentiator. AMPA receptors are fundamental to excitatory neurotransmission in the brain, and their enhanced activity is directly linked to improved synaptic plasticity. This plasticity is the biological basis for learning and memory, making HBT1 a valuable tool for studying and potentially improving these cognitive faculties. Secondly, HBT1 has been shown to stimulate the production of Brain-Derived Neurotrophic Factor (BDNF). BDNF is a crucial protein that supports the survival, growth, and differentiation of neurons, playing a vital role in brain health and resilience. The combined effect of AMPA-R potentiation and BDNF stimulation positions HBT1 as a compound of significant interest for a wide array of neuroscience applications. Researchers looking to buy HBT1 can rely on our commitment to quality.

The implications of HBT1's properties are vast, particularly concerning conditions characterized by cognitive decline. For instance, in neurodegenerative diseases like Alzheimer's, where memory loss and impaired learning are hallmark symptoms, compounds that bolster synaptic plasticity and support neuronal health are highly sought after. HBT1's ability to modulate AMPA-R activity and boost BDNF levels makes it a promising candidate for drug development aimed at mitigating these debilitating conditions. Scientists can explore its therapeutic potential by purchasing HBT1 for their detailed investigations. Furthermore, HBT1 is being explored for its impact on other complex neurological conditions such as schizophrenia and autism, where disruptions in neural circuit function are often observed. The precise modulation of neurotransmitter systems offered by HBT1 could pave the way for novel therapeutic strategies for these disorders.

As a leading pharmaceutical intermediate supplier, NINGBO INNO PHARMCHEM CO.,LTD. ensures that the scientific community has access to this vital compound. The availability of high-quality HBT1 from our facilities enables researchers to conduct thorough investigations into its therapeutic applications, contributing to significant advancements in the treatment of neurological and cognitive disorders. Sourcing high-purity HBT1 is a critical step for companies involved in pharmaceutical innovation and neurochemical research. We encourage you to inquire about our competitive price for bulk quantities and discover the advantages of working with a dedicated manufacturer.